CLINICAL RESPIRATORY JOURNAL, vol.12, no.4, pp.1628-1634, 2018 (Journal Indexed in SCI)
Article / Article
Title of Journal :
CLINICAL RESPIRATORY JOURNAL
long-term outcomes, pulmonary thromboembolism, thrombolytic therapy, DEEP-VEIN THROMBOSIS, PLASMINOGEN-ACTIVATOR, THROMBOLYTIC THERAPY, ANTITHROMBOTIC THERAPY, EUROPEAN-SOCIETY, TASK-FORCE, EMBOLISM, DIAGNOSIS, RISK, HYPERTENSION
BackgroundPulmonary thromboembolism (PTE) is a life-threatening disease. In this study, we aimed to evaluate long-term outcomes of the use of 50mg recombinant tissue-type plasminogen activator (rt-PA) in the management of PTE in terms of relapse, pulmonary hypertension (PH), mortality and hemorrhage and to compare with the use of 100mg rt-PA.